Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CTLA-4 blockade increases antigen-specific CD8+ T cells in prevaccinated patients with melanoma: three cases

4 Apr 2011

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Immunotherapy and Immune Responses
Share to vaccines and immunoinformatics approaches

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 21465316
DOI: 10.1007/s00262-011-1011-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CTLA-4 blockade increases antigen-specific CD8+ T cells in prevaccinated patients with melanoma: three casesPMID 21465316Read ↗

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patientsSemantic proximity Read ↗

Peripheral CD8+ T cell characteristics associated with durable responses to immune checkpoint blockade in patients with metastatic melanomaSemantic proximity Read ↗

Heterogeneity of CD8 T-Cell Changes in Advanced Melanomas After Initiation of ImmunotherapySemantic proximity Read ↗

Phenotypic characterization of tumor CTLA-4 expression in melanoma tissues and its possible role in clinical response to IpilimumabSemantic proximity Read ↗

Tumor evasion may occur via expression of regulatory molecules: a case for CTLA-4 in melanoma.Semantic proximity Read ↗

MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitroSemantic proximity Read ↗

[Cytotoxic T-cell immune response against melanoma antigens].Semantic proximity Read ↗

Overview of melanoma vaccines and promising approaches.Semantic proximity Read ↗

Markers for anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4) therapy in melanoma.Semantic proximity Read ↗

Analysis of a natural immune response against tumor antigens in a melanoma survivor: lessons applicable to clinical trial evaluations.Semantic proximity Read ↗

Characterization of long-term effector-memory T-cell responses in patients with resected high-risk melanoma receiving a melanoma Peptide vaccine.Semantic proximity Read ↗

Frequent occurrence of high affinity T cells against MELOE-1 makes this antigen an attractive target for melanoma immunotherapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.